Hudson Bay Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $37.6M | Buy |
|
|||||
|
2025
Q2 | $28.9M | Sell |
|
|||||
|
2025
Q1 | $41.5M | Buy |
|
|||||
|
2024
Q4 | $30.2M | Buy |
|
|||||
|
2024
Q3 | $31M | Buy |
|
|||||
|
2024
Q2 | $20.1M | Buy |
|
|||||
|
2024
Q1 | $9.6M | Buy |
|
|||||
|
2023
Q4 | $7.19M | Sell |
|
|||||
|
2023
Q3 | $11.6M | Buy |
|
|||||
|
2023
Q2 | $4.59M | Buy |
|
|||||
|
2023
Q1 | $2.92M | Sell |
|
|||||
|
2022
Q4 | $9.31M | Sell |
|
|||||
|
2022
Q3 | $8.9M | Sell |
|
|||||
|
2022
Q2 | $11.7M | Buy |
|
|||||
|
2022
Q1 | $3.66M | Buy |
|
|||||
|
2021
Q4 | $2.65M | Sell |
|
|||||
|
2021
Q3 | $7.73M | Buy |
|
|||||
|
2021
Q2 | $7.09M | Sell |
|
|||||
|
2021
Q1 | $6.99M | Sell |
|
|||||
|
2020
Q4 | $8.33M | Buy |
|
|||||
|
2020
Q3 | $3.93M | Sell |
|
|||||
|
2020
Q2 | $9.25M | Sell |
|
|||||
|
2020
Q1 | $7.18M | Sell |
|
|||||
|
2019
Q4 | $11.4M | Sell |
|
|||||
|
2019
Q3 | $11M | Buy |
|
|||||
|
2019
Q2 | $8.56M | Hold |
|
|||||
|
2019
Q1 | $8.88M | Sell |
|
|||||
|
2018
Q4 | $9.37M | Buy |
|
|||||
|
2018
Q3 | $9.7M | Hold |
|
|||||
|
2018
Q2 | $9.42M | Sell |
|
|||||
|
2018
Q1 | $11.3M | Buy |
|
|||||
|
2017
Q4 | $9.81M | Sell |
|
|||||
|
2017
Q3 | $17.3M | Buy |
|
|||||
|
2017
Q2 | $8.72M | Sell |
|
|||||
|
2017
Q1 | $14.1M | Buy |
|
|||||
|
2016
Q4 | $12M | Sell |
|
|||||
|
2016
Q3 | $18M | Buy |
|
|||||
|
2016
Q2 | $13.1M | Buy |
|
|||||
|
2016
Q1 | $7.42M | Buy |
|
|||||
|
2015
Q4 | $4.24M | Sell |
|
|||||
|
2015
Q3 | $9.5M | Sell |
|
|||||
|
2015
Q2 | $17.5M | Sell |
|
|||||
|
2015
Q1 | $19.3M | Buy |
|